Skip to main content
NVDA-2.40%AAPL+2.07%GOOGL+0.03%MSFT-0.04%AMZN+0.20%TSM-0.79%SPCX+2.01%AVGO+0.19%META+0.24%TSLA-0.36%SKHY-3.59%MU-3.98%BRK-B-0.16%LLY+0.62%JPM-0.48%AMD-2.20%WMT+0.12%V-0.23%XOM-0.14%ASMLa-1.48%JNJ-0.16%INTC-3.83%MA-0.51%0700.HK-1.94%ORCL-1.80%1398.HK+0.79%BAC-0.50%ABBV+0.44%CSCO-0.50%CVX-0.61%COST-0.10%LRCX-3.48%KO+0.82%CAT-0.87%AMAT-2.00%0005.HK-0.78%AP2d-1.26%UNH-0.75%DELL-2.68%HSBA.L-1.05%MS-0.15%PG-0.26%GE+0.09%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-0.98%GS-0.32%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%GBPJPY-1.39%EURNZD+1.38%EURJPY-1.36%CADJPY-1.36%NZDCAD-1.35%GBPNZD+1.31%NZDUSD-1.23%NZDCHF-1.06%USDNOK+0.94%EURNOK+0.90%CHFNOK+0.82%AUDNZD+0.78%NOKJPY-0.70%USDZAR+0.69%USDSEK+0.67%EURZAR+0.65%EURSEK+0.63%AUDDKK-0.62%AUDCAD-0.61%EURAUD+0.59%GBPZAR+0.55%CHFSEK+0.55%GBPAUD+0.53%AUDSGD-0.50%AUDUSD-0.45%USDMXN+0.43%GBPTRY+0.41%USDTHB+0.41%NZDSGD-0.34%GBPHKD+0.32%EURCHF+0.29%AUDNOK+0.29%GBPMXN-0.28%CADCHF+0.28%AUDCHF-0.28%GBPCHF+0.25%USDPLN+0.23%EURPLN+0.19%USDCHF+0.17%USDILS+0.16%USDSGD+0.15%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%USDTRY+0.11%GBPUSD+0.10%EURCZK-0.10%NZDMXN-0.09%SGDJPY+0.08%USDCNH+0.05%EURGBP+0.05%EURHKD-0.05%GBPCAD-0.05%USDCOP-0.04%EURCNH+0.04%CHFSGD+0.04%USDDKK+0.03%GBPSGD+0.02%PLNJPY+0.01%USDHKD+0.01%EURDKK0.00%EURCAD0.00%XPTUSD-4.76%HG1-4.48%GAGUSD-4.14%XAGUSD-4.14%UKOIL+3.50%USOIL+3.10%SUGAR+1.64%GAUUSD-0.92%XAUUSD-0.92%COTTON+0.71%S1+0.63%COFFEE-0.56%BTCUSD-1.22%ETHUSD-1.04%USDTUSD-0.02%XRPUSD-2.61%SOLUSD-1.44%TRXUSDT0.00%ZECUSDT-5.72%DOGEUSD-2.86%XMRUSDT-1.69%LINKUSD-1.08%XLMUSD-1.94%BCHUSDT-10.58%LTCUSD-1.72%UNIUSD-3.41%TONUSD+24.88%HBARUSDT-1.87%SUIUSD-3.40%TAOUSDT-5.14%AAVEUSD-2.85%DOTUSDT-3.61%ICPUSDT-0.90%ONDOUSDT-2.84%WLDUSDT-2.67%ATOMUSDT-3.41%ARBUSDT+1.37%JUPUSDT-2.96%INJUSDT-4.87%STXUSDT-3.07%FETUSDT-3.62%TIAUSDT-0.87%PYTHUSDT-0.07%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.89%OPUSDT-3.00%IOTAUSDT-3.86%POLUSDT-5.76%AXSUSDT-2.47%FARTCOINUSDT-2.74%EOSUSDT-0.68%DYDXUSDT-0.71%ORDIUSDT-0.85%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.40%AAPL+2.07%GOOGL+0.03%MSFT-0.04%AMZN+0.20%TSM-0.79%SPCX+2.01%AVGO+0.19%META+0.24%TSLA-0.36%SKHY-3.59%MU-3.98%BRK-B-0.16%LLY+0.62%JPM-0.48%AMD-2.20%WMT+0.12%V-0.23%XOM-0.14%ASMLa-1.48%JNJ-0.16%INTC-3.83%MA-0.51%0700.HK-1.94%ORCL-1.80%1398.HK+0.79%BAC-0.50%ABBV+0.44%CSCO-0.50%CVX-0.61%COST-0.10%LRCX-3.48%KO+0.82%CAT-0.87%AMAT-2.00%0005.HK-0.78%AP2d-1.26%UNH-0.75%DELL-2.68%HSBA.L-1.05%MS-0.15%PG-0.26%GE+0.09%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-0.98%GS-0.32%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%GBPJPY-1.39%EURNZD+1.38%EURJPY-1.36%CADJPY-1.36%NZDCAD-1.35%GBPNZD+1.31%NZDUSD-1.23%NZDCHF-1.06%USDNOK+0.94%EURNOK+0.90%CHFNOK+0.82%AUDNZD+0.78%NOKJPY-0.70%USDZAR+0.69%USDSEK+0.67%EURZAR+0.65%EURSEK+0.63%AUDDKK-0.62%AUDCAD-0.61%EURAUD+0.59%GBPZAR+0.55%CHFSEK+0.55%GBPAUD+0.53%AUDSGD-0.50%AUDUSD-0.45%USDMXN+0.43%GBPTRY+0.41%USDTHB+0.41%NZDSGD-0.34%GBPHKD+0.32%EURCHF+0.29%AUDNOK+0.29%GBPMXN-0.28%CADCHF+0.28%AUDCHF-0.28%GBPCHF+0.25%USDPLN+0.23%EURPLN+0.19%USDCHF+0.17%USDILS+0.16%USDSGD+0.15%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%USDTRY+0.11%GBPUSD+0.10%EURCZK-0.10%NZDMXN-0.09%SGDJPY+0.08%USDCNH+0.05%EURGBP+0.05%EURHKD-0.05%GBPCAD-0.05%USDCOP-0.04%EURCNH+0.04%CHFSGD+0.04%USDDKK+0.03%GBPSGD+0.02%PLNJPY+0.01%USDHKD+0.01%EURDKK0.00%EURCAD0.00%XPTUSD-4.76%HG1-4.48%GAGUSD-4.14%XAGUSD-4.14%UKOIL+3.50%USOIL+3.10%SUGAR+1.64%GAUUSD-0.92%XAUUSD-0.92%COTTON+0.71%S1+0.63%COFFEE-0.56%BTCUSD-1.22%ETHUSD-1.04%USDTUSD-0.02%XRPUSD-2.61%SOLUSD-1.44%TRXUSDT0.00%ZECUSDT-5.72%DOGEUSD-2.86%XMRUSDT-1.69%LINKUSD-1.08%XLMUSD-1.94%BCHUSDT-10.58%LTCUSD-1.72%UNIUSD-3.41%TONUSD+24.88%HBARUSDT-1.87%SUIUSD-3.40%TAOUSDT-5.14%AAVEUSD-2.85%DOTUSDT-3.61%ICPUSDT-0.90%ONDOUSDT-2.84%WLDUSDT-2.67%ATOMUSDT-3.41%ARBUSDT+1.37%JUPUSDT-2.96%INJUSDT-4.87%STXUSDT-3.07%FETUSDT-3.62%TIAUSDT-0.87%PYTHUSDT-0.07%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.89%OPUSDT-3.00%IOTAUSDT-3.86%POLUSDT-5.76%AXSUSDT-2.47%FARTCOINUSDT-2.74%EOSUSDT-0.68%DYDXUSDT-0.71%ORDIUSDT-0.85%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
QN

Qiagen N.V. (QGEN)

NYSE • Healthcare

$42.5
+$0.11 (+0.3%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$42.03
Previous Close$42.5
Day Range$41.91 - $42.73
Avg. Volume (3M)2.9M
Market Cap$8.7B
P/E Ratio21.8
52 Week Range
$32.53$57.82
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$535M100%
Gross Profitminus cost of goods$340.3M64%
Operating Incomeminus R&D and overhead$132.4M25%
Net Incomeminus taxes and the rest$103.4M19%

In plain terms: out of every $100 in revenue, Qiagen N.V. keeps $19 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.1B
Net Income (TTM)
$409.3M
EPS (TTM)
$1.95
ROA (TTM)
6.95%
Current Ratio
2.85
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1.6%Q1 2026$0.62
-0.4%Q2 2026$0.54
+3.7%Q3 2026$0.62
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +3.7%

Qiagen N.V. topped consensus on both adjusted EPS and revenue based on preliminary results for the second fiscal quarter of 2026 reported on Aug. 5, with adjusted EPS of $0.62 versus the $0.60 estimate and revenue of about $535.0 million versus $527.5 million, or roughly 4% and about 1% ahead, respectively. Revenue was roughly flat year over year, up 0.3% to about $535.0 million, while net income increased 7.4% to about $103.4 million from $96.2 million a year ago. Gross profit of about $338.0 million left gross margin at 63.2%, and operating income came to about $140.8 million with operating margin of 26.3%. Operating cash flow was about $200.7 million. Consensus for the next period calls for EPS of $0.63 on revenue of $551.3 million.

View full earnings history

About Qiagen N.V.

Qiagen N.V. (NYSE: QGEN) develops molecular testing and life-science tools for healthcare and research use, spanning diagnostic assays, laboratory consumables, instruments, and software. In FY2025, the company generated $2.1 billion in revenue. It serves the medical diagnostics and research market worldwide.

Name
Qiagen N.V.
CEO
Jon Pratt
Website
www.qiagen.com
Industry
Healthcare
Year Founded
1984
Employees
5,500

Today's Snapshot

AI-generated

The session opened with QGEN 1.2% lower at 42.00, in line with a flat sector. UBS, an investment bank, cut its price target for Qiagen.

Trading Volume

Below 10d avg (1.5M)

196.6K

vs S&P 500 Today

Moderate Outperformance

+0.36%

Updated: September 10, 2026 at 14:35 UTC

Technical Indicators

2 Buy3 Neutral3 Sell
QGEN presents a neutral stance with mixed short-term weakness against longer-term support and very little trend strength. The ADX is low, and momentum indicators are split: RSI and MACD are broadly neutral while CCI shows short-term downside pressure. Price is marginally below the 10–20 period averages yet above several 50–100 period measures, and the 200-day averages sit slightly overhead. Volatility is moderate and OBV is negative, but pivot levels are effectively neutral near the market. Technical takeaway: Neutral — balanced short-term weakness and longer-term support with low trend conviction.
All signals
  • EMA (5 indicators)$41.34 - $43.21
    Sell
  • RSI (14)46.28
    Neutral
  • Stochastic %K (14, 3, 3)23.93
    Neutral
  • MACD Level (12, 26)0.22
    Neutral

Peers & Related Assets

EXELExelixis, Inc.
$58.33+1.1%
RVTYRevvity, Inc.
$123.85-2.5%
CRLCharles River Laboratories International, Inc.
$278.35-0.9%
BAXBaxter International Inc.
$24.39-1.9%
BMRNBioMarin Pharmaceutical Inc.
$64.41-0.3%
TECHBio-Techne Corporation
$72.25-0.1%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.